Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,464.00    -26.00 (-1.74%)
Bid:
1,464.00
Ask:
1,468.00
Spread: 4.00 (0.273%)
Market Cap: £501.23m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

AGM Statement and Board Changes

13 Nov 2024 07:00

RNS Number : 9798L
Craneware plc
13 November 2024
 

Craneware plc

("Craneware" or the "Company")

 

AGM Statement and Board Changes

 

13 November 2024 - Craneware (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, provides an update on trading ahead of its Annual General Meeting, which takes place at 10am today.  

 

The Board is pleased to confirm that the positive momentum seen in FY24 has continued into the current year, with the prior investments into the Trisus platform supporting continued revenue and EBITDA growth. As a result, the Group continues to trade in line with current market expectations for the year ending 30 June 2025.

 

Following the election, US hospitals are now preparing for a period of stability and investment in strategic growth. We anticipate this will be a driver of demand for our solutions, as healthcare providers seek to optimise their operational and financial performance and maximise this investment. Alongside the Group's direct sales efforts, the recently signed alliance with Microsoft is progressing well, with Trisus offerings now live on the Azure Marketplace and the first sizeable customer contract secured via the marketplace.

 

The strength of the Company's balance sheet, high levels of recurring revenue and strong cash generation provide Craneware with solid foundations as it executes on its growth strategy. The Board remains confident in achieving growth acceleration over the near term, creating further long-term value for all stakeholders.

 

Board Changes

 

As previously announced, following many years' service on the Board of Directors, Colleen Blye, Senior Non-Executive Director, and Russ Rudish, Non-Executive Director, are not standing for re-election at the Company's AGM later today. The Board thanks them both for their significant contributions to Craneware's success to date.

 

The Company is pleased to announce the appointment of Tamra Minnier as Non-Executive Director, which will take effect following today's AGM. Tamra is an experienced senior US healthcare executive, currently holding the role of Senior Vice President, Health Services Division, and Chief Quality and Operational Excellence Officer for UPMC, a $27 billion-dollar integrated healthcare delivery and financing system in Pittsburgh, PA. Tamra's role includes overseeing the Wolff Center, the driving force for Quality and Safety, Nursing, Surgical Services, Pharmacy, Imaging and Laboratory Operations for UPMC and responsibility for The Beckwith Institute, a $23 million-dollar foundation supporting innovation in care delivery.

 

Following the completion of the AGM, David Kemp, will assume the role of Senior Independent Director, as well as continuing his role as Chair of the Audit Committee; Alistair Erskine will assume the role of Chair of the Remuneration Committee, and the appointment of Tamra Minnier will come into effect.

 

Additional information

 

The following information is being disclosed pursuant to Rule 17 and paragraph (g) of Schedule 2 of the AIM Rules for Companies in relation to the appointment of Tamra Minnier to the Board.

 

Tamra E. Minnier, aged 62, has been a director or partner of the following companies or partnerships during the five years preceding the date of this announcement:

 

Current:

 

· The United Way of Southwestern Pennsylvania

· Phipps Conservatory and Botanical Gardens, Inc.

· Aging Institute

· Infectious Disease Connect, Inc.

· The United Way of Western Pennsylvania

 

Historic:

 

· Joint Commission Resources, Inc.

· Patient Safety Movement Foundation

 

 

 

Save as set out above there are no further disclosures required pursuant to Rule 17 or Schedule Two, paragraph (g) of the AIM Rules for Companies.

 

 

For further information, please contact:

 

Craneware plc

+44 (0)131 550 3100

Keith Neilson, CEO

Craig Preston, CFO

 

Alma Strategic Communications (Financial PR)

+44 (0)20 3405 0205

Caroline Forde, Kinvara Verdon, Sarah Peters

craneware@almastrategic.com

 

Peel Hunt (NOMAD and Joint Broker) 

+44 (0)20 7418 8900

Neil Patel, Benjamin Cryer, Kate Bannatyne

 

Investec Bank PLC (Joint Broker)

+44 (0)20 7597 5970

Patrick Robb, Virginia Bull, Shalin Bhamra

  

 

Berenberg (Joint Broker)

+44 (0)20 3207 7800

Mark Whitmore, Richard Andrews, Dan Gee-Summons

 

About Craneware

 

The Craneware Group (AIM:CRW.L), is the market leader in value cycle solutions. For 25 years, we have collaborated with U.S. healthcare providers to optimize revenue integrity, pricing intelligence, decision support, labor productivity, business of pharmacy, and 340B program management. 

 

Customers choose Trisus®, a HITRUST- and SOC2 Type II-certified, SaaS platform, to achieve operational and financial excellence in pursuit of their healthcare mission - delivering quality care to their communities. The Craneware Group - Transforming the Business of Healthcare.

 

Learn more at www.thecranewaregroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFFFVILTLFLIS
Date   Source Headline
15th May 20268:36 amRNSNotification of Major Holdings
13th May 20266:11 pmRNSNotification of Major Holdings
13th May 20261:50 pmRNSNotification of Major Holdings
13th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
5th May 20265:11 pmRNSGrant of Share Options to Directors
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTransaction in Own Shares
27th Apr 202612:47 pmRNSNotification of Major Holdings
23rd Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSBlock Admission
13th Apr 202610:37 amRNSGrant of Share Option to PDMR
13th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 202611:26 amRNSDividend Currency Election
16th Mar 20267:00 amRNSShare buyback programme and Total Voting Rights
16th Mar 20267:00 amRNSShare buyback programme and Total Voting Rights
4th Mar 20267:00 amRNSDirector's Acquisition of Shares
2nd Mar 20267:00 amRNSFY26 Interim Results
18th Feb 20263:49 pmRNSNotification of Major Holdings
9th Feb 20264:55 pmRNSNotification of Major Holdings
3rd Feb 20263:16 pmRNSNotification of Major Holdings
20th Jan 20267:00 amRNSH1 FY26 Trading Update and Notice of Results
28th Nov 202511:31 amRNSDividend Currency Election
21st Nov 20251:51 pmRNSResult of AGM
21st Nov 20257:00 amRNSAGM Statement and Board Changes
20th Nov 20257:00 amRNSVesting of LTIP Awards and Total Voting Rights
13th Nov 202510:51 amRNSReduction of Capital effective
6th Nov 20253:41 pmRNSReduction of Capital confirmed
22nd Oct 20255:17 pmRNSAnnual Report, Notice of AGM, Directorate Change
22nd Oct 20259:24 amRNSTotal Voting Rights
15th Oct 20257:00 amRNSBlock listing Interim Review
17th Sep 20257:00 amRNSGrant of Long Term Incentive Plan Awards
15th Sep 20257:00 amRNSFY25 Final Results
1st Sep 20257:00 amRNSBank Refinancing
20th Aug 20256:22 pmRNSResult of General Meeting - Replacement
20th Aug 20254:28 pmRNSResult of AGM
1st Aug 20254:35 pmRNSProposed Reduction of Capital
16th Jul 20257:00 amRNSFY25 Trading Update
12th Jun 20253:20 pmRNSForm 8.3 - Craneware plc
12th Jun 202511:55 amRNSForm 8.5 (EPT/RI) - Craneware PLC
11th Jun 20253:00 pmRNSForm 8.3 - Craneware PLC
11th Jun 20252:47 pmRNSForm 8.3 - CRANEWARE PLC
11th Jun 20252:40 pmGNWForm 8.3 - Craneware Plc
11th Jun 202512:02 pmGNWForm 8.3 - [CRANEWARE PLC - 10 06 2025] - (CGWL)
11th Jun 202512:00 pmRNSForm 8.5 (EPT/RI) Craneware Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.